Kathleen Sebelius
Director · Humacyte, Inc.
- 2026
- Jun 12, 2026
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Kathleen Sebelius files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Dale A. Sander - $41K in HUMA purchases and sales in the last 12 months
- Shamik J. Parikh - $41K in HUMA purchases and sales in the last 12 months
- Keith Anthony Jones - $30K in HUMA purchases and sales in the last 12 months
- Michael T. Constantino - $10K in HUMA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Kathleen Sebelius?
Kathleen Sebelius is a corporate insider, tracked as Director of Humacyte, Inc. (HUMA). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Kathleen Sebelius last file a Form 4?
The most recent primary Form 4 on record is dated 12 June 2026, one of 2 filings going back to 2026.
Has Kathleen Sebelius been buying or selling stock?
Recorded transactions: 1 open-market purchase ($50K) and 0 open-market sales across all tracked filings.
